Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03180996 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Global Fenestrated Anaconda Clinical STudy

Study acronym: Global FACT
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study Identification, Study Status, Oversight, IPDSharingv17
  2. Minor Site details revised at 1 of 11 sitesv16
  3. Minor Primary completion date changed from estimate of Dec 31, 2021 to Mar 31, 2022v15
  4. Notable Primary completion date: Dec 31, 2020 to Dec 31, 2021
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 13 to 11
    • Study completion date: Dec 2030 to Dec 31, 2030
    v14
  5. Minor Primary completion date: Sep 2020 to Dec 31, 2020
    • Study completion date: Sep 2030 to Dec 2030
    v13
Show 11 earlier versionsHide 11 earlier versions
  1. Minor Site details revised at 1 of 13 sitesv12
  2. Minor Study sites: 14 to 13
    • Study completion date: Sep 2029 to Sep 2030
    v11
  3. Minor Site details revised at 1 of 14 sitesv10
  4. Minor Site details revised at 2 of 14 sitesv9
  5. Minor Site details revised at 2 of 14 sitesv8
  6. Minor Site details revised at 1 of 14 sitesv7
  7. Minor Study sites: 15 to 14v6
  8. Minor Site details revised at 1 of 15 sitesv5
  9. Minor Site details revised at 1 of 15 sitesv4
  10. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jul 2020 to Sep 2020
    • Study completion date: Jul 2029 to Sep 2029
    • Start date changed from estimate of Sep 2017 to Sep 11, 2017
    • Site details revised at 15 of 15 sites
  11. Notable Start date: Jul 2017 to Sep 2017
    • Study sites: 12 to 15
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
7 trials monitored
See 1 trial at risk
This study is a prospective non-interventional, multi-centre study of the Vascutek Fenestrated Anaconda™ system, and is essentially a post-market study. The Vascutek Fenestrated Anaconda™ system is a custom made device used for the treatment of Abdominal Aortic Aneurysm.
Trial Details
NCT Number NCT03180996
Lead Sponsor Vascutek Ltd.
Conditions
(from sponsor)
Abdominal Aortic Aneurysm
Related terms Aortic Aneurysm, Abdominal
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov